 Search:
|
|
|
 |
|
 |
| |
| Alan Bennett,
PUBLIC RELATIONS SPECIALIST, FOOD & DRUG ADMINISTRATION. |
FDA's Use of DSHEA to Ban Ephedra
Tuesday, May 4, 12:30 – 1:30 p.m.
Alan Bennett is responsible for the field FDA public affairs program
in Oregon, Idaho and Montana. He responds to inquiries about the FDA
from consumers, industry, academia, health care professionals, media
and state and local government agencies. Alan is a frequent speaker
on a variety of FDA issues and has spoken on past occasions on issues
such as the regulation of dietary supplements and genetically engineered
foods. He enjoys the challenge of presenting FDA rules and regulations,
which may at times, be complex, in an entertaining and understandable
manner. |
| Alta Charo, J.D.,
ELIZABETH S. WILSON - BASCOM PROFESSOR OF LAW AND BIOETHICS; ASSOCIATE
DEAN FOR RESEARCH AND FACULTY DEVELOPMENT, UNIVERSITY OF WISCONSIN
LAW SCHOOL. R. |
Stem Cell and Cloning Research
Tuesday, May 4, 4:00 – 5:00 p.m.
Alta Charo offers courses on health law, bioethics and biotechnology
law, food & drug law, medical ethics, reproductive rights, torts,
and legislative drafting. In addition, she has served on the UW Hospital
clinical ethics committee, the University's Institutional Review Board
for the protection of human subjects in medical research, and the
University's Bioethics Advisory Committee. Professor Charo is the
author of over 75 articles, book chapters and government reports on
topics including voting rights, environmental law, family planning
and abortion law, medical genetics law, reproductive technology policy,
and science policy and ethics. She currently serves on the editorial
boards of the "Journal of Law, Medicine and Ethics ," "Cloning:
Science and Policy," and the "Monash Bioethics Review. "
She serves on the expert advisory boards of three organizations with
an interest in stem cell research, CuresNow, the Juvenile Diabetes
Research Foundation; and WiCell, and serves on the International Association
for Bioethics and she has served as a consultant to the National Academy
of Science's Institute of Medicine and the NIH Office of Protection
from Research Risks. Alta Charo is also scheduled to conduct a breakout session at the
NW Regional IRB Conference on Tuesday, May 4th. |
| Helen McGough, M.A., CIP,
IRB ADMINISTRATOR, HUMAN SUBJECTS DIVISION, UNIVERSITY OF WASHINGTON |
Co-Facilitator, PRIM&R IRB 101
Helen McGough has supported the human subjects review function at the University of
Washington for over nineteen years. In her life before human subjects, she directed a
non-profit family services agency, served as a lobbyist for children’s issues, did
behavioral research in the areas of medical education and obstetrical practice, and
taught social science at the university level in the U.S. and overseas.
Helen has developed materials and presented them at international, national, regional,
and local conferences and workshops on a variety of topics related to the involvement
of humans in research. She has worked with groups of all sizes and from a wide variety
of educational and cultural backgrounds. She has developed and delivered training
materials for researchers, their staff, Institutional Review Board (IRB) members,
and community groups on the ethical conduct of research with human subjects. Helen
is the newsletter editor for the Applied Research Ethics National Association (ARENA),
and has published in the area of human subjects protections. She is a member of the
board of directors for Public Responsibility in Medicine and Research (PRIM&R), a
non-profit organization devoted to the ethical conduct of research, and serves as a
faculty member for PRIM&R’s 101 On-The-Road program. She is on the editorial board
of the journal, IRB, and is a member of the Board of Directors of the Association
for the Accreditation of Human Research Protection Programs.
|
| E. Haavi Morreim,
Ph.D., PROFESSOR, DEPARTMENT OF HUMAN VALUES AND ETHICS,
COLLEGE OF MEDICINE, UNIVERSITY OF TENNESSEE HEALTH SERVICE CENTER. |
Tales from the Trenches: Litigation in Clinical Research
Tuesday, May 4, 8:00 a.m. – 9:00 a.m.
E. Haavi Morreim, Ph.D., is a Professor of bioethics in the College
of Medicine, University of Tennessee. She also has a joint appointment
as Professor in the Division of Health Services and Policy Research,
Department of Preventive Medicine. For over twenty years, initially
at the University of Virginia School of Medicine and thereafter at
the University of Tennessee, she has done clinical teaching and consulting
in medical ethics. She also chairs the Independent Patient Advocacy
Council created to serve patients enrolled in the AbioCor artificial
heart trial. She served on President Clinton's National Bioethics
Advisory Commission from 1996-2001.
Dr. Morreim serves on the editorial board of several journals, including
IRB: Ethics and Human Research, and the Journal of Law, Medicine &
Ethics. She is author of two books and over a hundred publications
in journals of law, medicine, and ethics, including the Journal of
the American Medical Association, Archives of Internal Medicine, California
Law Review, Hastings Center Report, and the Wall Street Journal. Her
first book, Balancing Act: the New Medical Ethics of Medicine's New
Economics, first appeared in 1991 and was republished in paperback
by Georgetown University Press in 1995. Her new book, Holding Health
Care Accountable: Law and the New Medical Marketplace, was published
by Oxford in 2001. Dr. Morreim is scheduled to conduct a breakout
session at the NW Regional IRB Conference on Tuesday, May 4th. |
| Ernest D. Prentice, Ph.D,
ASSOCIATE DEAN OF RESEARCH, PROFESSOR OF ANATOMY, UNIVERSITY OF NEBRASKA MEDICAL CENTER |
Co-Facilitator, PRIM&R IRB 101
Dr. Ernest D. Prentice is the Associate Vice Chancellor for Academic Affairs
at the University of Nebraska Medical Center (UNMC). He is also Professor of
Cell Biology and Anatomy and Professor of Preventive and Societal Medicine. Dr.
Prentice has served as co-chair of the UNMC Institutional Review Board (IRB) for
over 23 years. In addition to his scholarly work in the fields of anatomy and
medical education, Dr. Prentice is the author of numerous articles on the ethics
and regulation of both human and animal research and he is a frequent speaker at
meetings on various aspects of research ethics. He serves as a consultant to
universities, hospitals and law firms in the private sector. Dr. Prentice is
often a member of national panels and writing groups addressing various
aspects of research ethics and regulatory oversight of research. He is a
member of the Association for the Accreditation of Human Research
Protection Programs (AAHRPP) council and serves as Chairman of the Health
and Human Services Secretary's Advisory Committee on Human Research Protection (SACHRP). |
Last modified on 04/06/2004 by
rdaweb@ohsu.edu
|
|
 |
|
 |
|
